PMCUF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PMCUF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pro Medicus's Free Cash Flow for the six months ended in Jun. 2024 was $33.1 Mil. Pro Medicus's Revenue for the six months ended in Jun. 2024 was $58.0 Mil. Therefore, Pro Medicus's FCF Margin % for the quarter that ended in Jun. 2024 was 57.01%.
As of today, Pro Medicus's current FCF Yield % is 0.30%.
The historical rank and industry rank for Pro Medicus's FCF Margin % or its related term are showing as below:
During the past 13 years, the highest FCF Margin % of Pro Medicus was 56.27%. The lowest was -7.92%. And the median was 37.82%.
The historical data trend for Pro Medicus's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro Medicus Annual Data | |||||||||||||||||||||
Trend | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | Jun24 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial | 41.47 | 45.92 | 56.27 | 44.95 | 46.64 |
Pro Medicus Semi-Annual Data | ||||||||||||||||||||
Dec14 | Jun15 | Dec15 | Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
FCF Margin % | Get a 7-Day Free Trial | 60.84 | 29.40 | 57.94 | 34.41 | 57.01 |
For the Health Information Services subindustry, Pro Medicus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Pro Medicus's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Pro Medicus's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as
FCF Margin | = | Free Cash Flow (A: Jun. 2024 ) | / | Revenue (A: Jun. 2024 ) |
= | 49.991 | / | 107.191 | |
= | 46.64 % |
Pro Medicus's FCF Margin for the quarter that ended in Jun. 2024 is calculated as
FCF Margin | = | Free Cash Flow (Q: Jun. 2024 ) | / | Revenue (Q: Jun. 2024 ) |
= | 33.066 | / | 58.005 | |
= | 57.01 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Pro Medicus's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
From GuruFocus
By PRNewswire PRNewswire • 08-05-2021
By PRNewswire PRNewswire • 11-30-2020
By PRNewswire PRNewswire • 11-14-2022
By GuruFocus Research • 02-14-2024
By PRNewswire PRNewswire • 02-08-2023
By GuruFocus Research • 08-15-2024
By PRNewswire PRNewswire • 06-26-2020
By PRNewswire PRNewswire • 11-23-2021
By PRNewswire • 11-12-2024
By PRNewswire PRNewswire • 11-16-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.